Oxford University Press, The Journal of Infectious Diseases, 8(205), p. 1248-1257, 2012
Full text: Download
Background. Although broadly neutralizing antibodies (bNAbs) have been shown to block a diverse array of cell-free human immunodeficiency type 1 (HIV-1) infections, it remains unclear whether these antibodies exhibit similar potency against mature dendritic cell (mDC)–mediated HIV-1 trans-infection.